← Back to Search

CHATO Training for Dementia

N/A
Recruiting
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Exclusion criteria from MDS include active psychiatric diagnoses (bipolar disorder, major depressive episode, schizophrenia or schizoaffective disorder, mood disorder with psychotic features, psychotic symptoms, hallucinations or delusions); terminal illness (on hospice); and lack of verbal or non-verbal response to staff (MDS section B)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre (1 year), post (1 year)
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a new online training program for nursing home staff to see if it improves communication and reduces behavioral symptoms in people with dementia.

Who is the study for?
This trial is for nursing homes with internet access, willing to have staff complete CHATO training and participate in interviews/surveys. It's aimed at improving care for residents with Alzheimer's or other dementias. Staff providing direct care for 8+ hours weekly will do the training. Facilities that served in prior CHAT/CHATO studies, assisted living, or those with residents on hospice or certain psychiatric conditions are excluded.
What is being tested?
The study tests an online interactive training program (CHATO) designed to enhance communication skills of nursing home staff. The goal is to improve interactions with dementia patients and reduce their behavioral symptoms, contributing to better overall care.
What are the potential side effects?
Since this intervention involves educational training without medical procedures or drugs, there are no traditional side effects. However, participants may experience changes in workload or stress levels due to new practices implemented from the training.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have severe mental health issues, am not in hospice care, and can communicate with staff.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre (1 year), post (1 year)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre (1 year), post (1 year) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
AIM 1. Test CHATO's effects on Behavioral and Psychological Symptoms of Dementia (BPSD) - Change in MDS E0200 at 3 and 6 months
AIM 1. Test CHATO's effects on Behavioral and Psychological Symptoms of Dementia (BPSD) - Change in MDS E0800 at 3 and 6 months
AIM 1. Test CHATO's effects on Behavioral and Psychological Symptoms of Dementia (BPSD) - Change in MDS E1100 at 3 and 6 months
+6 more
Secondary study objectives
AIM 3. Evaluate CHATO Cost (3 months of training)
Aim 3. Evaluate CHATO Sustainability (1 year post-training)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Intervention nursing homes will receive the training and control nursing homes will complete assessments, but not receive the training.
Group II: Waitlist ControlActive Control1 Intervention
After the intervention nursing homes complete the training, the waitlist control nursing homes will crossover and complete the training.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Changing Talk Online (CHATO)
2019
N/A
~220

Find a Location

Who is running the clinical trial?

University of IowaOTHER
468 Previous Clinical Trials
891,691 Total Patients Enrolled
University of Kansas Medical CenterLead Sponsor
510 Previous Clinical Trials
175,099 Total Patients Enrolled

Media Library

Changing Talk Online (CHATO) Clinical Trial Eligibility Overview. Trial Name: NCT04610944 — N/A
Alzheimer's Disease Research Study Groups: Waitlist Control, Intervention
Alzheimer's Disease Clinical Trial 2023: Changing Talk Online (CHATO) Highlights & Side Effects. Trial Name: NCT04610944 — N/A
Changing Talk Online (CHATO) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04610944 — N/A
~510 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top